It can be perfectly comprehended that IL-two is usually a pleiotropic cytokine positioned at the crossroads of T mobile activation and regulation. Therefore, it's critical to engineer an IL-2 molecule that's biased in the direction of effector cells bearing the intermediate affinity receptor, for example naïve and memory CD8+ T cells and NK cells,